Clinical Trial Update: Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects [Phase 2]

View source ↗

Summary

Phase 2 study of the ChimeriVax Dengue Tetravalent Vaccine in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Hemorrhagic Fever

Drugs mentioned

• ChimeriVax Dengue Tetravalent Vaccine (Chimeric tetravalent dengue vaccine)

Snippet

Sponsor: Sanofi | Conditions: Dengue, Dengue Fever | Phase 2 | Status: COMPLETED